AC Immune Announces Pricing of Underwritten Offering of Common Shares
15 déc. 2023 07h56 HE
|
AC Immune SA
AC Immune Announces Pricing of Underwritten Offering of Common Shares Lausanne, Switzerland, December 15, 2023 – AC Immune SA (Nasdaq: ACIU) (the “Company” or “AC Immune”), a clinical-stage...
Draganfly Announces Closing of US$3.5 Million Underwritten Offering
30 oct. 2023 17h19 HE
|
Draganfly Inc
Los Angeles, CA., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions, and...
Draganfly Announces Pricing of US$3.5 Million Underwritten Offering
26 oct. 2023 09h53 HE
|
Draganfly Inc
Los Angeles, CA., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions, and...
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
24 févr. 2020 08h00 HE
|
Trxade Group, Inc.
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
31 janv. 2020 07h30 HE
|
Nephros, Inc.
SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance...
Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
25 janv. 2019 09h01 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading...